Status:
TERMINATED
Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis
Lead Sponsor:
Nicolas Hunzelmann
Collaborating Sponsors:
University Hospital Tuebingen
Conditions:
Systemic Scleroderma
Systemic Sclerosis
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
Systemic scleroderma (SSc) is a rare chronic inflammatory diseae of the connective tissue involving the skin and internal organs. To date there is no proven therapy for the skin fibrosis available. A ...
Eligibility Criteria
Inclusion
- systemic sclerosis ACR criteria
- skin fibrosis at least involving the distal third of the lower arm
Exclusion
- photosensitizing drugs
- recent UV therapy
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00628797
Start Date
February 1 2008
End Date
November 1 2013
Last Update
May 31 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Tuebingen, Dept. of Dermatology
Tübingen, Baden-Wurttemberg, Germany, 72076
2
University of Cologne, Dept. of Dermatology
Cologne, North Rhine-Westphalia, Germany, 50937